➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Colorcon
McKesson
Moodys
Dow

Last Updated: June 23, 2021

DrugPatentWatch Database Preview

ETRETINATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for etretinate and what is the scope of patent protection?

Etretinate is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for ETRETINATE
Recent Clinical Trials for ETRETINATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4
M.D. Anderson Cancer CenterPhase 2

See all ETRETINATE clinical trials

Medical Subject Heading (MeSH) Categories for ETRETINATE

US Patents and Regulatory Information for ETRETINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986 DISCN No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ETRETINATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986   Get Started Free   Get Started Free
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986   Get Started Free   Get Started Free
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986   Get Started Free   Get Started Free
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKinsey
Express Scripts
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.